$LOAN
Manhattan Bridge Capital Inc

2016 Q2 Form 10-Q Financial Statement

#000114420416114807 Filed on July 28, 2016

View on sec.gov

Income Statement

Concept 2016 Q2 2016 Q1 2015 Q4
Revenue $1.166M $1.105M $1.150M
YoY Change 27.85% 21.15% 27.78%
Cost Of Revenue
YoY Change
Gross Profit
YoY Change
Gross Profit Margin
Selling, General & Admin $230.0K $230.0K $340.0K
YoY Change 9.52% -8.0% 6.25%
% of Gross Profit
Research & Development
YoY Change
% of Gross Profit
Depreciation & Amortization $0.00 $862.00 $10.00K
YoY Change -45.82%
% of Gross Profit
Operating Expenses $230.0K $230.0K $340.0K
YoY Change 9.52% -11.54% 6.25%
Operating Profit $721.7K $695.8K
YoY Change 32.32% 46.31%
Interest Expense -$210.0K -$180.0K -$200.0K
YoY Change 40.0% 0.0% 11.11%
% of Operating Profit -29.1% -25.87%
Other Income/Expense, Net $0.00
YoY Change
Pretax Income $711.7K $700.0K $590.0K
YoY Change 34.17% 47.18% 47.5%
Income Tax $1.639K $508.00 $0.00
% Of Pretax Income 0.23% 0.07% 0.0%
Net Earnings $710.1K $695.3K $590.0K
YoY Change 33.86% 46.2% 47.5%
Net Earnings / Revenue 60.9% 62.95% 51.3%
Basic Earnings Per Share $0.10 $0.10
Diluted Earnings Per Share $0.10 $0.10 $81.49K
COMMON SHARES
Basic Shares Outstanding 7.279M shares 7.264M shares 7.231M shares
Diluted Shares Outstanding 7.308M shares 7.292M shares

Balance Sheet

Concept 2016 Q2 2016 Q1 2015 Q4
SHORT-TERM ASSETS
Cash & Short-Term Investments $130.0K $60.00K $110.0K
YoY Change 160.0% -76.92% 120.0%
Cash & Equivalents $130.0K $60.00K $106.8K
Short-Term Investments
Other Short-Term Assets $1.470M $510.0K $32.87K
YoY Change 2000.0% 875.07% 21.74%
Inventory
Prepaid Expenses
Receivables
Other Receivables
Total Short-Term Assets $25.19M $20.36M $20.72M
YoY Change 64.96% 16.12% 6.66%
LONG-TERM ASSETS
Property, Plant & Equipment $10.00K $8.947K $8.771K
YoY Change -50.0% -48.87% -54.05%
Goodwill
YoY Change
Intangibles
YoY Change
Long-Term Investments $40.00K $50.00K $50.00K
YoY Change -20.0% -28.57% -28.57%
Other Assets $90.00K $320.0K $170.0K
YoY Change -35.71% 2460.0%
Total Long-Term Assets $8.980M $9.970M $10.94M
YoY Change -20.32% 42.92% 117.94%
TOTAL ASSETS
Total Short-Term Assets $25.19M $20.36M $20.72M
Total Long-Term Assets $8.980M $9.970M $10.94M
Total Assets $34.17M $30.33M $31.66M
YoY Change 28.75% 23.74% 29.5%
SHORT-TERM LIABILITIES
YoY Change
Accounts Payable $90.00K $130.0K $100.0K
YoY Change 0.0% 85.71% -37.5%
Accrued Expenses
YoY Change
Deferred Revenue
YoY Change
Short-Term Debt $0.00 $860.6K $1.096M
YoY Change -100.0% -21.45% -55.63%
Long-Term Debt Due $9.470M $10.65M $11.82M
YoY Change 35.48% 14.27% 53.51%
Total Short-Term Liabilities $10.25M $11.89M $13.91M
YoY Change 22.75% 11.73% 31.53%
LONG-TERM LIABILITIES
Long-Term Debt $5.280M $0.00 $0.00
YoY Change
Other Long-Term Liabilities
YoY Change
Total Long-Term Liabilities $5.280M $0.00 $0.00
YoY Change
TOTAL LIABILITIES
Total Short-Term Liabilities $10.25M $11.89M $13.91M
Total Long-Term Liabilities $5.280M $0.00 $0.00
Total Liabilities $15.53M $11.89M $13.91M
YoY Change 85.96% 11.75% 31.51%
SHAREHOLDERS EQUITY
Retained Earnings $391.6K $299.6K -$395.7K
YoY Change -449.11%
Common Stock $18.62M $18.51M $18.51M
YoY Change 31.05%
Preferred Stock
YoY Change
Treasury Stock (at cost) $369.3K $369.3K $369.3K
YoY Change 0.0%
Treasury Stock Shares 177.0K shares 177.0K shares 177.0K shares
Shareholders Equity $18.64M $18.44M $17.74M
YoY Change
Total Liabilities & Shareholders Equity $34.17M $30.33M $31.66M
YoY Change 28.73% 23.74% 29.5%

Cashflow Statement

Concept 2016 Q2 2016 Q1 2015 Q4
OPERATING ACTIVITIES
Net Income $710.1K $695.3K $590.0K
YoY Change 33.86% 46.2% 47.5%
Depreciation, Depletion And Amortization $0.00 $862.00 $10.00K
YoY Change -45.82%
Cash From Operating Activities $830.0K $710.0K $620.0K
YoY Change 72.92% 153.57% 24.0%
INVESTING ACTIVITIES
Capital Expenditures $0.00 $1.038K -$10.00K
YoY Change -50.0%
Acquisitions
YoY Change
Other Investing Activities -$3.130M $1.900M -$1.760M
YoY Change 46.26% 603.7% 100.0%
Cash From Investing Activities -$3.120M $1.890M -$1.760M
YoY Change 45.12% 600.0% 95.56%
FINANCING ACTIVITIES
Cash Dividend Paid $617.4K
YoY Change 26.86%
Common Stock Issuance & Retirement, Net
YoY Change
Debt Paid & Issued, Net
YoY Change
Cash From Financing Activities 2.360M -2.650M 1.190M
YoY Change 62.76% 679.41% 197.5%
NET CHANGE
Cash From Operating Activities 830.0K 710.0K 620.0K
Cash From Investing Activities -3.120M 1.890M -1.760M
Cash From Financing Activities 2.360M -2.650M 1.190M
Net Change In Cash 70.00K -50.00K 50.00K
YoY Change -131.82% -123.81% -85899345920001900.0%
FREE CASH FLOW
Cash From Operating Activities $830.0K $710.0K $620.0K
Capital Expenditures $0.00 $1.038K -$10.00K
Free Cash Flow $830.0K $709.0K $630.0K
YoY Change 72.92% 153.2% 21.15%

Facts In Submission

Frame Concept Type Concept / XBRL Key Value Unit
CY2015Q2 us-gaap Loans And Leases Receivable Gross Carrying Amount
LoansAndLeasesReceivableGrossCarryingAmount
25907258 USD
CY2015Q2 us-gaap Weighted Average Number Of Shares Outstanding Basic
WeightedAverageNumberOfSharesOutstandingBasic
6470905 shares
us-gaap Weighted Average Number Of Shares Outstanding Basic
WeightedAverageNumberOfSharesOutstandingBasic
7271685 shares
us-gaap Weighted Average Number Of Shares Outstanding Basic
WeightedAverageNumberOfSharesOutstandingBasic
6280278 shares
CY2016Q2 us-gaap Weighted Average Number Of Diluted Shares Outstanding
WeightedAverageNumberOfDilutedSharesOutstanding
7307710 shares
CY2015Q2 us-gaap Weighted Average Number Of Diluted Shares Outstanding
WeightedAverageNumberOfDilutedSharesOutstanding
6507384 shares
us-gaap Weighted Average Number Of Diluted Shares Outstanding
WeightedAverageNumberOfDilutedSharesOutstanding
7298185 shares
us-gaap Weighted Average Number Of Diluted Shares Outstanding
WeightedAverageNumberOfDilutedSharesOutstanding
6314909 shares
CY2016Q2 us-gaap Loans And Leases Receivable Gross Carrying Amount
LoansAndLeasesReceivableGrossCarryingAmount
32133870 USD
CY2016Q2 us-gaap Weighted Average Number Diluted Shares Outstanding Adjustment
WeightedAverageNumberDilutedSharesOutstandingAdjustment
28378 shares
CY2016Q2 us-gaap Preferred Stock Value
PreferredStockValue
0 USD
CY2016Q2 us-gaap Common Stock Value
CommonStockValue
7469 USD
CY2016Q2 us-gaap Additional Paid In Capital Common Stock
AdditionalPaidInCapitalCommonStock
18607753 USD
CY2016Q2 us-gaap Treasury Stock Value
TreasuryStockValue
369335 USD
CY2016Q2 us-gaap Retained Earnings Accumulated Deficit
RetainedEarningsAccumulatedDeficit
391623 USD
CY2016Q2 us-gaap Stockholders Equity
StockholdersEquity
18637510 USD
CY2016Q2 us-gaap Liabilities And Stockholders Equity
LiabilitiesAndStockholdersEquity
34165505 USD
CY2016Q2 us-gaap Short Term Borrowings
ShortTermBorrowings
0 USD
CY2015Q4 us-gaap Short Term Borrowings
ShortTermBorrowings
1095620 USD
CY2016Q2 us-gaap Lines Of Credit Current
LinesOfCreditCurrent
9469589 USD
CY2015Q4 us-gaap Lines Of Credit Current
LinesOfCreditCurrent
11821099 USD
CY2016Q2 us-gaap Restricted Cash And Cash Equivalents
RestrictedCashAndCashEquivalents
1408592 USD
CY2015Q4 us-gaap Restricted Cash And Cash Equivalents
RestrictedCashAndCashEquivalents
0 USD
us-gaap Net Income Loss
NetIncomeLoss
1006035 USD
us-gaap Net Income Loss
NetIncomeLoss
1405390 USD
us-gaap Amortization Of Financing Costs
AmortizationOfFinancingCosts
15460 USD
us-gaap Amortization Of Financing Costs
AmortizationOfFinancingCosts
39433 USD
us-gaap Share Based Compensation
ShareBasedCompensation
6832 USD
us-gaap Share Based Compensation
ShareBasedCompensation
6794 USD
us-gaap Increase Decrease In Accrued Interest Receivable Net
IncreaseDecreaseInAccruedInterestReceivableNet
99892 USD
us-gaap Increase Decrease In Accrued Interest Receivable Net
IncreaseDecreaseInAccruedInterestReceivableNet
-82207 USD
us-gaap Increase Decrease In Other Operating Assets
IncreaseDecreaseInOtherOperatingAssets
40987 USD
us-gaap Increase Decrease In Other Operating Assets
IncreaseDecreaseInOtherOperatingAssets
26730 USD
us-gaap Increase Decrease In Accounts Payable And Accrued Liabilities
IncreaseDecreaseInAccountsPayableAndAccruedLiabilities
-76609 USD
us-gaap Increase Decrease In Accounts Payable And Accrued Liabilities
IncreaseDecreaseInAccountsPayableAndAccruedLiabilities
-10057 USD
loan Increase Decrease In Deferred Origination Fees
IncreaseDecreaseInDeferredOriginationFees
69327 USD
loan Increase Decrease In Deferred Origination Fees
IncreaseDecreaseInDeferredOriginationFees
-31729 USD
us-gaap Net Cash Provided By Used In Operating Activities Continuing Operations
NetCashProvidedByUsedInOperatingActivitiesContinuingOperations
759712 USD
us-gaap Net Cash Provided By Used In Operating Activities Continuing Operations
NetCashProvidedByUsedInOperatingActivitiesContinuingOperations
1540544 USD
loan Issuance Of Short Term Loans
IssuanceOfShortTermLoans
8825000 USD
loan Issuance Of Short Term Loans
IssuanceOfShortTermLoans
14869500 USD
us-gaap Proceeds From Principal Repayments On Loans And Leases Held For Investment
ProceedsFromPrincipalRepaymentsOnLoansAndLeasesHeldForInvestment
6950218 USD
us-gaap Proceeds From Principal Repayments On Loans And Leases Held For Investment
ProceedsFromPrincipalRepaymentsOnLoansAndLeasesHeldForInvestment
13639670 USD
us-gaap Net Cash Provided By Used In Investing Activities Continuing Operations
NetCashProvidedByUsedInInvestingActivitiesContinuingOperations
-1875466 USD
us-gaap Net Cash Provided By Used In Investing Activities Continuing Operations
NetCashProvidedByUsedInInvestingActivitiesContinuingOperations
-1231329 USD
us-gaap Proceeds From Issuance Of Shares Under Incentive And Share Based Compensation Plans Including Stock Options
ProceedsFromIssuanceOfSharesUnderIncentiveAndShareBasedCompensationPlansIncludingStockOptions
24368 USD
us-gaap Proceeds From Issuance Of Shares Under Incentive And Share Based Compensation Plans Including Stock Options
ProceedsFromIssuanceOfSharesUnderIncentiveAndShareBasedCompensationPlansIncludingStockOptions
100463 USD
us-gaap Payments Of Dividends
PaymentsOfDividends
973822 USD
us-gaap Payments Of Dividends
PaymentsOfDividends
1235503 USD
us-gaap Net Cash Provided By Used In Financing Activities Continuing Operations
NetCashProvidedByUsedInFinancingActivitiesContinuingOperations
1113439 USD
us-gaap Net Cash Provided By Used In Financing Activities Continuing Operations
NetCashProvidedByUsedInFinancingActivitiesContinuingOperations
-288551 USD
us-gaap Cash And Cash Equivalents Period Increase Decrease
CashAndCashEquivalentsPeriodIncreaseDecrease
-2315 USD
us-gaap Cash And Cash Equivalents Period Increase Decrease
CashAndCashEquivalentsPeriodIncreaseDecrease
20664 USD
CY2014Q4 us-gaap Cash And Cash Equivalents At Carrying Value
CashAndCashEquivalentsAtCarryingValue
47676 USD
CY2015Q2 us-gaap Cash And Cash Equivalents At Carrying Value
CashAndCashEquivalentsAtCarryingValue
45361 USD
us-gaap Income Taxes Paid
IncomeTaxesPaid
0 USD
us-gaap Income Taxes Paid
IncomeTaxesPaid
1948 USD
us-gaap Interest Paid
InterestPaid
318317 USD
us-gaap Interest Paid
InterestPaid
348443 USD
us-gaap Depreciation
Depreciation
3200 USD
us-gaap Depreciation
Depreciation
1778 USD
us-gaap Payments To Acquire Property Plant And Equipment
PaymentsToAcquirePropertyPlantAndEquipment
1499 USD
us-gaap Payments To Acquire Property Plant And Equipment
PaymentsToAcquirePropertyPlantAndEquipment
684 USD
us-gaap Proceeds From Repayments Of Lines Of Credit
ProceedsFromRepaymentsOfLinesOfCredit
-2351510 USD
us-gaap Proceeds From Repayments Of Lines Of Credit
ProceedsFromRepaymentsOfLinesOfCredit
-706389 USD
us-gaap Payments Of Financing Costs
PaymentsOfFinancingCosts
0 USD
us-gaap Payments Of Financing Costs
PaymentsOfFinancingCosts
111400 USD
loan Cash Restricted For Reduction Of Line Of Credit
CashRestrictedForReductionOfLineOfCredit
1408592 USD
loan Cash Restricted For Reduction Of Line Of Credit
CashRestrictedForReductionOfLineOfCredit
0 USD
us-gaap Repayments Of Debt
RepaymentsOfDebt
1095620 USD
us-gaap Repayments Of Debt
RepaymentsOfDebt
1373845 USD
CY2016Q2 us-gaap Preferred Stock Par Or Stated Value Per Share
PreferredStockParOrStatedValuePerShare
0.01
CY2015Q4 us-gaap Preferred Stock Par Or Stated Value Per Share
PreferredStockParOrStatedValuePerShare
0.01
CY2016Q2 us-gaap Preferred Stock Shares Authorized
PreferredStockSharesAuthorized
5000000 shares
CY2015Q4 us-gaap Preferred Stock Shares Authorized
PreferredStockSharesAuthorized
5000000 shares
CY2016Q2 us-gaap Preferred Stock Shares Issued
PreferredStockSharesIssued
0 shares
CY2015Q4 us-gaap Preferred Stock Shares Issued
PreferredStockSharesIssued
0 shares
CY2016Q2 us-gaap Common Stock Par Or Stated Value Per Share
CommonStockParOrStatedValuePerShare
0.001
CY2015Q4 us-gaap Common Stock Par Or Stated Value Per Share
CommonStockParOrStatedValuePerShare
0.001
CY2016Q2 us-gaap Common Stock Shares Authorized
CommonStockSharesAuthorized
25000000 shares
CY2015Q4 us-gaap Common Stock Shares Authorized
CommonStockSharesAuthorized
25000000 shares
CY2016Q2 us-gaap Common Stock Shares Issued
CommonStockSharesIssued
7469239 shares
CY2015Q4 us-gaap Common Stock Shares Issued
CommonStockSharesIssued
7441039 shares
CY2016Q2 us-gaap Common Stock Shares Outstanding
CommonStockSharesOutstanding
7292239 shares
CY2015Q4 us-gaap Common Stock Shares Outstanding
CommonStockSharesOutstanding
7264039 shares
CY2016Q2 us-gaap Treasury Stock Shares
TreasuryStockShares
177000 shares
CY2015Q4 us-gaap Treasury Stock Shares
TreasuryStockShares
177000 shares
CY2016Q2 loan Interest Income From Loans
InterestIncomeFromLoans
973934 USD
CY2015Q2 loan Interest Income From Loans
InterestIncomeFromLoans
764329 USD
loan Interest Income From Loans
InterestIncomeFromLoans
1888243 USD
loan Interest Income From Loans
InterestIncomeFromLoans
1521079 USD
CY2016Q2 loan Origination Fees
OriginationFees
191959 USD
CY2015Q2 loan Origination Fees
OriginationFees
147625 USD
loan Origination Fees
OriginationFees
382240 USD
loan Origination Fees
OriginationFees
302636 USD
CY2016Q2 us-gaap Revenues
Revenues
1165893 USD
CY2015Q2 us-gaap Revenues
Revenues
911954 USD
us-gaap Revenues
Revenues
2270483 USD
us-gaap Revenues
Revenues
1823715 USD
CY2016Q2 loan Interest And Amortization Of Debt Service Costs
InterestAndAmortizationOfDebtServiceCosts
208750 USD
CY2015Q2 loan Interest And Amortization Of Debt Service Costs
InterestAndAmortizationOfDebtServiceCosts
150721 USD
loan Referral Fees
ReferralFees
3262 USD
loan Referral Fees
ReferralFees
2312 USD
CY2016Q2 us-gaap General And Administrative Expense
GeneralAndAdministrativeExpense
233545 USD
CY2015Q2 us-gaap General And Administrative Expense
GeneralAndAdministrativeExpense
214679 USD
us-gaap General And Administrative Expense
GeneralAndAdministrativeExpense
461385 USD
us-gaap General And Administrative Expense
GeneralAndAdministrativeExpense
466591 USD
CY2016Q2 us-gaap Operating Costs And Expenses
OperatingCostsAndExpenses
444189 USD
CY2015Q2 us-gaap Operating Costs And Expenses
OperatingCostsAndExpenses
366515 USD
us-gaap Operating Costs And Expenses
OperatingCostsAndExpenses
852947 USD
us-gaap Operating Costs And Expenses
OperatingCostsAndExpenses
802680 USD
CY2016Q2 us-gaap Operating Income Loss
OperatingIncomeLoss
721704 USD
CY2015Q2 us-gaap Operating Income Loss
OperatingIncomeLoss
545439 USD
us-gaap Operating Income Loss
OperatingIncomeLoss
1417536 USD
us-gaap Operating Income Loss
OperatingIncomeLoss
1021035 USD
CY2016Q2 us-gaap Costmethod Investments Other Than Temporary Impairment
CostmethodInvestmentsOtherThanTemporaryImpairment
10000 USD
CY2015Q2 us-gaap Costmethod Investments Other Than Temporary Impairment
CostmethodInvestmentsOtherThanTemporaryImpairment
15000 USD
us-gaap Costmethod Investments Other Than Temporary Impairment
CostmethodInvestmentsOtherThanTemporaryImpairment
10000 USD
us-gaap Costmethod Investments Other Than Temporary Impairment
CostmethodInvestmentsOtherThanTemporaryImpairment
15000 USD
CY2016Q2 us-gaap Net Income Loss
NetIncomeLoss
710065 USD
CY2015Q2 us-gaap Net Income Loss
NetIncomeLoss
530439 USD
CY2016Q2 us-gaap Income Tax Expense Benefit
IncomeTaxExpenseBenefit
1639 USD
CY2015Q2 us-gaap Income Tax Expense Benefit
IncomeTaxExpenseBenefit
0 USD
us-gaap Income Tax Expense Benefit
IncomeTaxExpenseBenefit
2146 USD
us-gaap Income Tax Expense Benefit
IncomeTaxExpenseBenefit
0 USD
CY2016Q2 us-gaap Income Loss From Continuing Operations Before Income Taxes Extraordinary Items Noncontrolling Interest
IncomeLossFromContinuingOperationsBeforeIncomeTaxesExtraordinaryItemsNoncontrollingInterest
711704 USD
CY2015Q2 us-gaap Income Loss From Continuing Operations Before Income Taxes Extraordinary Items Noncontrolling Interest
IncomeLossFromContinuingOperationsBeforeIncomeTaxesExtraordinaryItemsNoncontrollingInterest
530439 USD
us-gaap Income Loss From Continuing Operations Before Income Taxes Extraordinary Items Noncontrolling Interest
IncomeLossFromContinuingOperationsBeforeIncomeTaxesExtraordinaryItemsNoncontrollingInterest
1407536 USD
us-gaap Income Loss From Continuing Operations Before Income Taxes Extraordinary Items Noncontrolling Interest
IncomeLossFromContinuingOperationsBeforeIncomeTaxesExtraordinaryItemsNoncontrollingInterest
1006035 USD
CY2015Q2 us-gaap Earnings Per Share Basic
EarningsPerShareBasic
0.08
us-gaap Earnings Per Share Basic
EarningsPerShareBasic
0.19
us-gaap Earnings Per Share Basic
EarningsPerShareBasic
0.16
CY2016Q2 us-gaap Earnings Per Share Diluted
EarningsPerShareDiluted
0.10
CY2015Q2 us-gaap Earnings Per Share Diluted
EarningsPerShareDiluted
0.08
us-gaap Earnings Per Share Diluted
EarningsPerShareDiluted
0.19
us-gaap Earnings Per Share Diluted
EarningsPerShareDiluted
0.16
CY2016Q2 us-gaap Weighted Average Number Of Shares Outstanding Basic
WeightedAverageNumberOfSharesOutstandingBasic
7279332 shares
CY2015Q4 us-gaap Liabilities Current
LiabilitiesCurrent
13913487 USD
us-gaap Weighted Average Number Diluted Shares Outstanding Adjustment
WeightedAverageNumberDilutedSharesOutstandingAdjustment
34631 shares
CY2011Q3 loan Fair Value Of Restricted Shares Granted
FairValueOfRestrictedSharesGranted
195968 USD
CY2011Q3 loan Fair Value Of Restricted Shares Amortization Period
FairValueOfRestrictedSharesAmortizationPeriod
P15Y
CY2016Q2 us-gaap Share Based Compensation
ShareBasedCompensation
3397 USD
CY2015Q2 us-gaap Share Based Compensation
ShareBasedCompensation
3416 USD
CY2014Q3 loan Warrants To Purchase Common Stock
WarrantsToPurchaseCommonStock
87719 shares
CY2014Q3 loan Warrants Exercise Price
WarrantsExercisePrice
3.5625
CY2014Q3 us-gaap Stock And Warrants Issued During Period Value Preferred Stock And Warrants
StockAndWarrantsIssuedDuringPeriodValuePreferredStockAndWarrants
42224 USD
CY2015Q2 loan Warrants Exercise Price
WarrantsExercisePrice
5.4875
CY2015Q2 us-gaap Stock And Warrants Issued During Period Value Preferred Stock And Warrants
StockAndWarrantsIssuedDuringPeriodValuePreferredStockAndWarrants
54928 USD
CY2016Q2 us-gaap Liabilities Current
LiabilitiesCurrent
10249461 USD
CY2016Q1 us-gaap Short Term Borrowings
ShortTermBorrowings
860620 USD
CY2016Q2 us-gaap Liabilities
Liabilities
15527995 USD
CY2015Q4 us-gaap Liabilities
Liabilities
13913487 USD
CY2013Q4 us-gaap Cost Method Investments
CostMethodInvestments
65000 USD
CY2015Q2 us-gaap Cost Method Investments
CostMethodInvestments
50000 USD
CY2016Q2 us-gaap Earnings Per Share Basic
EarningsPerShareBasic
0.10
CY2016Q2 loan Net Proceeds From Issuance Initial Public Offering
NetProceedsFromIssuanceInitialPublicOffering
5300000 USD
CY2016Q2 loan Gross Proceeds From Issuance Initial Public Offering
GrossProceedsFromIssuanceInitialPublicOffering
6000000 USD
loan Operating Lease Term Of Lease
OperatingLeaseTermOfLease
five years and two months
CY2016Q2 loan Aggregate Of Commercial Loans Issued
AggregateOfCommercialLoansIssued
230000 USD
CY2014Q3 loan Warrants Expiry Date
WarrantsExpiryDate
2019-07-28
CY2015Q2 loan Warrants Expiry Date
WarrantsExpiryDate
2020-05-22
loan Sharebased Compensation Arrangement By Sharebased Payment Award Award Vesting Rights For Employee And Nonemployee Directors
SharebasedCompensationArrangementBySharebasedPaymentAwardAwardVestingRightsForEmployeeAndNonemployeeDirectors
Historically, until the year ended December 31, 2014, each non-employee director of the Company was granted an option for 7,000 common shares upon first taking office, and received an annual option grant for an additional 7,000 common shares for each additional year in office. Generally, options outstanding vest over periods not exceeding four years and are exercisable for up to five years from the grant date.
CY2016Q2 us-gaap Dividends Payable Current
DividendsPayableCurrent
0 USD
CY2015Q4 us-gaap Dividends Payable Current
DividendsPayableCurrent
617443 USD
CY2016Q2 us-gaap Secured Long Term Debt
SecuredLongTermDebt
5278534 USD
CY2015Q4 us-gaap Secured Long Term Debt
SecuredLongTermDebt
0 USD
CY2016Q2 us-gaap Commitments And Contingencies
CommitmentsAndContingencies
USD
CY2015Q4 us-gaap Commitments And Contingencies
CommitmentsAndContingencies
USD
CY2016Q2 us-gaap Deferred Finance Costs Net
DeferredFinanceCostsNet
721466 USD
CY2016Q2 loan Due To Joint Venture Partners
DueToJointVenturePartners
378875 USD
CY2015Q4 loan Due To Joint Venture Partners
DueToJointVenturePartners
0 USD
loan Proceeds From Public Offering
ProceedsFromPublicOffering
5323336 USD
loan Proceeds From Public Offering
ProceedsFromPublicOffering
4254527 USD
loan Proceeds From Collected Payable To Joint Venture Partners
ProceedsFromCollectedPayableToJointVenturePartners
378875 USD
loan Proceeds From Collected Payable To Joint Venture Partners
ProceedsFromCollectedPayableToJointVenturePartners
0 USD
CY2016Q2 loan Restricted Cash Includes Collections Received From Loans
RestrictedCashIncludesCollectionsReceivedFromLoans
378575 USD
CY2016Q2 us-gaap Short Term Borrowings
ShortTermBorrowings
0 USD
CY2015Q2 loan Warrants To Purchase Common Stock
WarrantsToPurchaseCommonStock
50750 shares

Files In Submission

Name View Source Status
0001144204-16-114807-index-headers.html Edgar Link pending
0001144204-16-114807-index.html Edgar Link pending
0001144204-16-114807.txt Edgar Link pending
0001144204-16-114807-xbrl.zip Edgar Link pending
ex10-6pg01.jpg Edgar Link pending
ex10-6pg02.jpg Edgar Link pending
ex10-6pg03.jpg Edgar Link pending
ex10-6pg04.jpg Edgar Link pending
ex10-6pg05.jpg Edgar Link pending
ex10-6pg06.jpg Edgar Link pending
ex10-6pg07.jpg Edgar Link pending
ex10-6pg08.jpg Edgar Link pending
ex10-6pg09.jpg Edgar Link pending
ex10-6pg10.jpg Edgar Link pending
ex10-6pg11.jpg Edgar Link pending
ex10-6pg12.jpg Edgar Link pending
ex10-6pg13.jpg Edgar Link pending
ex10-6pg14.jpg Edgar Link pending
ex10-6pg15.jpg Edgar Link pending
ex10-6pg16.jpg Edgar Link pending
ex10-6pg17.jpg Edgar Link pending
ex10-6pg18.jpg Edgar Link pending
ex10-6pg19.jpg Edgar Link pending
ex10-6pg20.jpg Edgar Link pending
ex10-6pg21.jpg Edgar Link pending
ex10-6pg22.jpg Edgar Link pending
ex10-6pg23.jpg Edgar Link pending
ex10-6pg24.jpg Edgar Link pending
ex10-6pg25.jpg Edgar Link pending
ex10-6pg26.jpg Edgar Link pending
ex10-6pg27.jpg Edgar Link pending
ex10-6pg28.jpg Edgar Link pending
ex10-6pg29.jpg Edgar Link pending
ex10-6pg30.jpg Edgar Link pending
ex10-6pg31.jpg Edgar Link pending
FilingSummary.xml Edgar Link unprocessable
Financial_Report.xlsx Edgar Link pending
loan-20160630.xml Edgar Link completed
loan-20160630.xsd Edgar Link pending
loan-20160630_cal.xml Edgar Link unprocessable
loan-20160630_def.xml Edgar Link unprocessable
loan-20160630_lab.xml Edgar Link unprocessable
loan-20160630_pre.xml Edgar Link unprocessable
R1.htm Edgar Link pending
R10.htm Edgar Link pending
R11.htm Edgar Link pending
R12.htm Edgar Link pending
R13.htm Edgar Link pending
R14.htm Edgar Link pending
R15.htm Edgar Link pending
R16.htm Edgar Link pending
R17.htm Edgar Link pending
R18.htm Edgar Link pending
R19.htm Edgar Link pending
R2.htm Edgar Link pending
R20.htm Edgar Link pending
R21.htm Edgar Link pending
R22.htm Edgar Link pending
R23.htm Edgar Link pending
R24.htm Edgar Link pending
R25.htm Edgar Link pending
R26.htm Edgar Link pending
R27.htm Edgar Link pending
R28.htm Edgar Link pending
R29.htm Edgar Link pending
R3.htm Edgar Link pending
R30.htm Edgar Link pending
R31.htm Edgar Link pending
R4.htm Edgar Link pending
R5.htm Edgar Link pending
R6.htm Edgar Link pending
R7.htm Edgar Link pending
R8.htm Edgar Link pending
R9.htm Edgar Link pending
report.css Edgar Link pending
Show.js Edgar Link pending
v444303_10q.htm Edgar Link pending
v444303_ex10-6.htm Edgar Link pending
v444303_ex10-7.htm Edgar Link pending
v444303_ex31-1.htm Edgar Link pending
v444303_ex31-2.htm Edgar Link pending
v444303_ex32-1.htm Edgar Link pending
v444303_ex32-2.htm Edgar Link pending